The FDA said Stryker had marketed devices without approval, and pointed out that the device manufacturer failed to notify the regulatory body of a product recall, according to the report. Stryker submitted a plan to correct the quality and recall issues.
More Articles on Devices:
13 Recent Device Company Executive & Leadership Changes
NLT Spine Opens US Subsidiary
Alphatec Solus Fusion Device Receives FDA 510(k) Clearance
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
